PM
TFFP

Precept Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Precept Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-600
Closed -$144K – 113
2021
Q2 		$144K Sell
600
-3,692
-86% -$1.01M 0.06% 72
2021
Q1 		$1.46M Sell
4,292
-1,708
-28% -$695K 0.99% 29
2020
Q4 		$2.15M Sell
6,000
-3,412
-36% -$1.31M 0.87% 25
2020
Q3 		$4.35M Buy
9,412
+3,560
+61% +$1M 1.07% 27
2020
Q2 		$843K Hold
5,852
– – 0.16% 64
2020
Q1 		$562K Hold
5,852
– – 0.07% 94
2019
Q4 		$783K Buy
+5,852
New +$751K 0.38% 54

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Precept Management's TFFP Position: Q3 2021 in Review

Precept Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 600 shares — an estimated $144K sold.

Precept Management first reported a position in TFFP in Q4 2019 and held it in 7 quarters. The position peaked at $4.35M in Q3 2020. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • Precept Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Precept Management sold 600 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $144K.
  • Precept Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Precept Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $4.35M in Q3 2020.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Precept Management's 13F filing for Q3 2021, filed 15 Nov 2021.